Breaking News

Metrics Appoints BD Head

October 7, 2013

Dopf brings 20 years of industry experience

Jeffrey Dopf has been appointed to head business development efforts at Metrics Inc.’s West Coast and Midwest markets. Mr. Dopf will work to identify and expand new business opportunities with current and potential clients.
 
Mr. Dopf brings 20 years of experience in the pharmaceutical industry. He spent seven years as the business development manager for Glatt Pharmaceutical Services in the oral solid dosage contract service and drug delivery division, where he was responsible for managing drug delivery development projects involving proprietary pelleting technology. Prior to Glatt, he worked for Patheon Pharmaceutical Services Inc., managing commercial sales. 

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016